What is Dermaquest?
Dermaquest operates as a specialized entity within the professional skincare industry, leveraging over two decades of expertise to develop advanced, results-oriented treatments. The company distinguishes itself through a rigorous focus on clinical-grade formulations that address complex dermatological concerns, including acne, hyperpigmentation, and premature aging. By bridging the gap between medical-grade efficacy and consumer accessibility, Dermaquest has established a robust footprint in both professional aesthetic clinics and the broader retail skincare market. Their product portfolio, which encompasses sophisticated serums, cleansers, and targeted treatment kits, reflects a commitment to progressive skin health science and long-term therapeutic outcomes.
How much funding has Dermaquest raised?
Dermaquest has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Dermaquest
PPP
Public-Private Partnership
What's next for Dermaquest?
Following this late-stage capital injection, Dermaquest is poised to transition into a phase of aggressive operational scaling and product diversification. The strategic deployment of these funds will likely prioritize the expansion of their distribution channels and the enhancement of their research and development capabilities to maintain a competitive edge in the rapidly evolving skincare landscape. As the company matures, management is expected to focus on deepening its penetration in international markets and potentially exploring new technological integrations within their treatment protocols. This financial backing provides the necessary runway to solidify Dermaquest's position as a leader in the professional skincare segment, ensuring sustained growth and continued innovation in clinical-grade product development.
See full Dermaquest company page
